The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4

doi:10.1084/jem.183.3.915

This Article

Full Text (PDF, 1384K)

Alert me when this article is cited

Citation Map

Services

Email this article

Similar articles in this journal

Similar articles in PubMed

Alert me to new content in the JEM

Download to citation manager

Citing Articles

Citing Articles via HighWire

Citing Articles via CrossRef

Citing Articles via Google Scholar

Google Scholar

Articles by Levitsky, V.

Articles by Masucci, M. G.

Search for Related Content

PubMed

PubMed Citation

Articles by Levitsky, V.

Articles by Masucci, M. G.

Pubmed/NCBI databases

Substance via MeSH

Social Bookmarking

What's this?

ARTICLES

The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4

V Levitsky, QJ Zhang, J Levitskaya and MG Masucci
Microbiology and Tumor Biology Center, Karolinska Institute, Stockholm, Sweden.

We have investigated the reactivity to two human histocompatibility leukocyte antigen (HLA) A11-restricted cytotoxic T lymphocyte (CTL) epitopes derived from amino acids 416-424 (IVTDFSVIK, designated IVT) and 399-408 (AVFDRKSVAK, designated AVF) of the Epstein-Barr virus (EBV) nuclear antigen (EBNA) 4. A strong predominance of CTL clones specific for the IVT epitope was demonstrated in polyclonal cultures generated by stimulation of lymphocytes from the EBV-seropositive donor BK with the autologous B95.8 virus-transformed lymphoblastoid cell line (LCL). This was not due to intrinsic differences of CTL efficiency since clones specific for the two epitopes lysed equally well A11- positive phytohemagglutinin blasts and LCLs pulsed with the relevant synthetic peptide. Irrespective of the endogenous levels of EBNA4 expression, untreated LCLs were lysed more efficiently by the IVT- specific effectors, suggesting that a higher density of A11-IVT complexes is presented at the cell surface. In accordance, 10-50-fold higher amounts of IVT peptides were found in high-performance liquid chromatography fractions of acid extracts corresponding to an abundance of about 350-12,800 IVT and 8-760 AVF molecules per cell. Peptide- mediated competition of CTL sensitization, transport assays in streptolysin-O permeabilized cells, and induction of A11 expression in the transporter associated with antigen presentation-deficient T2/A11 transfectant demonstrated that the IVT and AVF peptides bind with similar affinities to A11, are translocated with equal efficiency to the endoplasmic reticulum, and form complexes of comparable stability over a wide range of temperature and pH conditions. A rapid surface turnover of A11 molecules containing the AVF peptide was demonstrated in metabolically active T2/A11 cells corresponding to a half-life of approximately 3.5 as compared to approximately 2 h for molecules induced at 26 degrees C in the absence of exogenous peptides and >12 h for IVT-containing complexes. This difference in persistence is likely to determine the representation of individual class I-restricted CTL epitopes within the cell surface pool of molecules, and may be an important factor contributing to their immunogenicity.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

Johansen, P., Storni, T., Rettig, L., Qiu, Z., Der-Sarkissian, A., Smith, K. A., Manolova, V., Lang, K. S., Senti, G., Mullhaupt, B., Gerlach, T., Speck, R. F., Bot, A., Kundig, T. M. (2008). Antigen kinetics determines immune reactivity. Proc. Natl. Acad. Sci. USA 105: 5189-5194 [Abstract] [Full Text]
Haigh, T. A., Lin, X., Jia, H., Hui, E. P., Chan, A. T. C., Rickinson, A. B., Taylor, G. S. (2008). EBV Latent Membrane Proteins (LMPs) 1 and 2 as Immunotherapeutic Targets: LMP-Specific CD4+ Cytotoxic T Cell Recognition of EBV-Transformed B Cell Lines. J. Immunol. 180: 1643-1654 [Abstract] [Full Text]
Hasegawa, A., Moriya, C., Liu, H., Charini, W. A., Vinet, H. C., Subbramanian, R. A., Sen, P., Letvin, N. L., Kuroda, M. J. (2007). Analysis of TCR{alpha}beta Combinations used by Simian Immunodeficiency Virus-Specific CD8+ T Cells in Rhesus Monkeys: Implications for CTL Immunodominance. J. Immunol. 178: 3409-3417 [Abstract] [Full Text]
Tong, J. C., Tan, T. W., Ranganathan, S. (2007). Methods and protocols for prediction of immunogenic epitopes. Brief Bioinform 8: 96-108 [Abstract] [Full Text]
York, I. A., Brehm, M. A., Zendzian, S., Towne, C. F., Rock, K. L. (2006). Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc. Natl. Acad. Sci. USA 103: 9202-9207 [Abstract] [Full Text]
Margalit, A., Sheikhet, H. M., Carmi, Y., Berko, D., Tzehoval, E., Eisenbach, L., Gross, G. (2006). Induction of Antitumor Immunity by CTL Epitopes Genetically Linked to Membrane-Anchored {beta}2-Microglobulin. J. Immunol. 176: 217-224 [Abstract] [Full Text]
Uhlin, M., Masucci, M. G., Levitsky, V. (2005). Regulation of lck degradation and refractory state in CD8+ cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 102: 9264-9269 [Abstract] [Full Text]
Long, H. M., Haigh, T. A., Gudgeon, N. H., Leen, A. M., Tsang, C.-W., Brooks, J., Landais, E., Houssaint, E., Lee, S. P., Rickinson, A. B., Taylor, G. S. (2005). CD4+ T-Cell Responses to Epstein-Barr Virus (EBV) Latent-Cycle Antigens and the Recognition of EBV-Transformed Lymphoblastoid Cell Lines. J. Virol. 79: 4896-4907 [Abstract] [Full Text]
Sakai, Y., Morrison, B. J., Burke, J. D., Park, J.-M., Terabe, M., Janik, J. E., Forni, G., Berzofsky, J. A., Morris, J. C. (2004). Vaccination by Genetically Modified Dendritic Cells Expressing a Truncated neu Oncogene Prevents Development of Breast Cancer in Transgenic Mice. Cancer Res. 64: 8022-8028 [Abstract] [Full Text]
Webster, G. J. M., Reignat, S., Brown, D., Ogg, G. S., Jones, L., Seneviratne, S. L., Williams, R., Dusheiko, G., Bertoletti, A. (2004). Longitudinal Analysis of CD8+ T Cells Specific for Structural and Nonstructural Hepatitis B Virus Proteins in Patients with Chronic Hepatitis B: Implications for Immunotherapy. J. Virol. 78: 5707-5719 [Abstract] [Full Text]
Yoshimura, Y., Yadav, R., Christianson, G. J., Ajayi, W. U., Roopenian, D. C., Joyce, S. (2004). Duration of Alloantigen Presentation and Avidity of T Cell Antigen Recognition Correlate with Immunodominance of CTL Response to Minor Histocompatibility Antigens. J. Immunol. 172: 6666-6674 [Abstract] [Full Text]
Webb, A. I., Dunstone, M. A., Chen, W., Aguilar, M.-I., Chen, Q., Jackson, H., Chang, L., Kjer-Nielsen, L., Beddoe, T., McCluskey, J., Rossjohn, J., Purcell, A. W. (2004). Functional and Structural Characteristics of NY-ESO-1-related HLA A2-restricted Epitopes and the Design of a Novel Immunogenic Analogue. J. Biol. Chem. 279: 23438-23446 [Abstract] [Full Text]
Kambayashi, T., Kraft-Leavy, J. R., Dauner, J. G., Sullivan, B. A., Laur, O., Jensen, P. E. (2004). The Nonclassical MHC Class I Molecule Qa-1 Forms Unstable Peptide Complexes. J. Immunol. 172: 1661-1669 [Abstract] [Full Text]
Midgley, R. S., Bell, A. I., Yao, Q. Y., Croom-Carter, D., Hislop, A. D., Whitney, B. M., Chan, A. T. C., Johnson, P. J., Rickinson, A. B. (2003). HLA-A11-Restricted Epitope Polymorphism among Epstein-Barr Virus Strains in the Highly HLA-A11-Positive Chinese Population: Incidence and Immunogenicity of Variant Epitope Sequences. J. Virol. 77: 11507-11516 [Abstract] [Full Text]
Ong, K.-W., Wilson, A. D., Hirst, T. R., Morgan, A. J. (2003). The B Subunit of Escherichia coli Heat-Labile Enterotoxin Enhances CD8+ Cytotoxic-T-Lymphocyte Killing of Epstein-Barr Virus-Infected Cell Lines. J. Virol. 77: 4298-4305 [Abstract] [Full Text]
DiPaolo, R. J., Unanue, E. R. (2002). Cutting Edge: Chemical Dominance Does Not Relate to Immunodominance: Studies of the CD4+ T Cell Response to a Model Antigen. J. Immunol. 169: 1-4 [Abstract] [Full Text]
Smith, S. G., Patel, P. M., Porte, J., Selby, P. J., Jackson, A. M. (2001). Human Dendritic Cells Genetically Engineered to Express a Melanoma Polyepitope DNA Vaccine Induce Multiple Cytotoxic T-Cell Responses. Clin. Cancer Res. 7: 4253-4261 [Abstract] [Full Text]
Yague, J., Marina, A., Vazquez, J., Lopez de Castro, J. A. (2001). Major Histocompatibility Complex Class I Molecules Bind Natural Peptide Ligands Lacking the Amino-terminal Binding Residue in Vivo. J. Biol. Chem. 276: 43699-43707 [Abstract] [Full Text]
Herberts, C. A., Stittelaar, K. J., van der Heeft, E., van Gaans-van den Brink, J., Poelen, M. C. M., Roholl, P. J. M., van Alphen, L. J. W., Melief, C. J. M., de Jong, A. P. J. M., van Els, C. A. C. M. (2001). A measles virus glycoprotein-derived human CTL epitope is abundantly presented via the proteasomal-dependent MHC class I processing pathway. J. Gen. Virol. 82: 2131-2142 [Abstract] [Full Text]
Skoberne, M., Holtappels, R., Hof, H., Geginat, G. (2001). Dynamic Antigen Presentation Patterns of Listeria monocytogenes-Derived CD8 T Cell Epitopes In Vivo. J. Immunol. 167: 2209-2218 [Abstract] [Full Text]
Gottschalk, S., Ng, C. Y. C., Perez, M., Smith, C. A., Sample, C., Brenner, M. K., Heslop, H. E., Rooney, C. M. (2001). An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs. Blood 97: 835-843 [Abstract] [Full Text]
Micheletti, F., Canella, A., Vertuani, S., Marastoni, M., Tosi, L., Volinia, S., Traniello, S., Gavioli, R. (2000). Supra-Agonist Peptides Enhance the Reactivation of Memory CTL Responses. J. Immunol. 165: 4264-4271 [Abstract] [Full Text]
Marshall, N. A., Howe, J. G., Formica, R., Krause, D., Wagner, J. E., Berliner, N., Crouch, J., Pilip, I., Cooper, D., Blazar, B. R., Seropian, S., Pamer, E. G. (2000). Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation. Blood 96: 2814-2821 [Abstract] [Full Text]
Dela Cruz, C. S., Tan, R., Rowland-Jones, S. L., Barber, B. H. (2000). Creating HIV-1 reverse transcriptase cytotoxic T lymphocyte target structures by HLA-A2 heavy chain modifications. Int Immunol 12: 1293-1302 [Abstract] [Full Text]
Crotzer, V. L., Christian, R. E., Brooks, J. M., Shabanowitz, J., Settlage, R. E., Marto, J. A., White, F. M., Rickinson, A. B., Hunt, D. F., Engelhard, V. H. (2000). Immunodominance Among EBV-Derived Epitopes Restricted by HLA-B27 Does Not Correlate with Epitope Abundance in EBV-Transformed B-Lymphoblastoid Cell Lines. J. Immunol. 164: 6120-6129 [Abstract] [Full Text]
Zhang, Q.-J., Chen, S. S., Saari, C.-A., Massuci, M. G., Tufaro, F., Jefferies, W. A. (2000). Evidence of Selective Processing of Immunodominant Epitopes in Virally Infected Cells. J. Immunol. 164: 4513-4521 [Abstract] [Full Text]
Loing, E., Andrieu, M., Thiam, K., Schorner, D., Wiesmuller, K.-H., Hosmalin, A., Jung, G., Gras-Masse, H. (2000). Extension of HLA-A*0201-Restricted Minimal Epitope by N{epsilon}-Palmitoyl-lysine Increases the Life Span of Functional Presentation to Cytotoxic T Cells. J. Immunol. 164: 900-907 [Abstract] [Full Text]
Loyer, V., Fontaine, P., Pion, S., Hetu, F., Roy, D.-C., Perreault, C. (1999). The In Vivo Fate of APCs Displaying Minor H Antigen and/or MHC Differences Is Regulated by CTLs Specific for Immunodominant Class I-Associated Epitopes. J. Immunol. 163: 6462-6467 [Abstract] [Full Text]
Wherry, E. J., Puorro, K. A., Porgador, A., Eisenlohr, L. C. (1999). The Induction of Virus-Specific CTL as a Function of Increasing Epitope Expression: Responses Rise Steadily Until Excessively High Levels of Epitope Are Attained. J. Immunol. 163: 3735-3745 [Abstract] [Full Text]
Chu, P. G., Chang, K. L., Chen, W.-G., Chen, Y.-Y., Shibata, D., Hayashi, K., Bacchi, C., Bacchi, M., Weiss, L. M. (1999). Epstein-Barr Virus (EBV) Nuclear Antigen (EBNA)-4 Mutation in EBV-Associated Malignancies in Three Different Populations. Am. J. Pathol. 155: 941-947 [Abstract] [Full Text]
Murray, P. G., Billingham, L. J., Hassan, H. T., Flavell, J. R., Nelson, P. N., Scott, K., Reynolds, G., Constandinou, C. M., Kerr, D. J., Devey, E. C., Crocker, J., Young, L. S. (1999). Effect of Epstein-Barr Virus Infection on Response to Chemotherapy and Survival in Hodgkin's Disease. Blood 94: 442-447 [Abstract] [Full Text]
Johnson, A. J., Njenga, M. K., Hansen, M. J., Kuhns, S. T., Chen, L., Rodriguez, M., Pease, L. R. (1999). Prevalent Class I-Restricted T-Cell Response to the Theiler's Virus Epitope Db:VP2121-130 in the Absence of Endogenous CD4 Help, Tumor Necrosis Factor Alpha, Gamma Interferon, Perforin, or Costimulation through CD28. J. Virol. 73: 3702-3708 [Abstract] [Full Text]
Vijh, S., Pilip, I. M., Pamer, E. G. (1999). Noncompetitive Expansion of Cytotoxic T Lymphocytes Specific for Different Antigens during Bacterial Infection. Infect. Immun. 67: 1303-1309 [Abstract] [Full Text]
Pion, S., Christianson, G. J., Fontaine, P., Roopenian, D. C., Perreault, C. (1999). Shaping the Repertoire of Cytotoxic T-Lymphocyte Responses: Explanation for the Immunodominance Effect Whereby Cytotoxic T Lymphocytes Specific for Immunodominant Antigens Prevent Recognition of Nondominant Antigens. Blood 93: 952-962 [Abstract] [Full Text]
Reali, E., Guerrini, R., Marastoni, M., Tomatis, R., Grazia Masucci, M., Traniello, S., Gavioli, R. (1999). A Single Specific Amino Acid Residue in Peptide Antigens Is Sufficient to Activate Memory CTL: Potential Role of Cross-Reactive Peptides in Memory T Cell Maintenance. J. Immunol. 162: 106-113 [Abstract] [Full Text]
Brooks, J. M., Colbert, R. A., Mear, J. P., Leese, A. M., Rickinson, A. B. (1998). HLA-B27 Subtype Polymorphism and CTL Epitope Choice: Studies with EBV Peptides Link Immunogenicity with Stability of the B27:Peptide Complex. J. Immunol. 161: 5252-5259 [Abstract] [Full Text]
Wolpert, E. Z., Grufman, P., Sandberg, J. K., Tegnesjo, A., Karre, K. (1998). Immunodominance in the CTL Response Against Minor Histocompatibility Antigens: Interference Between Responding T Cells, Rather than with Presentation of Epitopes. J. Immunol. 161: 4499-4505 [Abstract] [Full Text]
Levitsky, V., de Campos-Lima, P.-O., Frisan, T., Masucci, M. G. (1998). The Clonal Composition of a Peptide-Specific Oligoclonal CTL Repertoire Selected in Response to Persistent EBV Infection Is Stable Over Time. J. Immunol. 161: 594-601 [Abstract] [Full Text]
Gallimore, A., Dumrese, T., Hengartner, H., Zinkernagel, R. M., Rammensee, H.-G. (1998). Protective Immunity Does Not Correlate with the Hierarchy of Virus-specific Cytotoxic T Cell Responses to Naturally Processed Peptides. JEM 187: 1647-1657 [Abstract] [Full Text]
Busch, D. H., Pamer, E. G. (1998). MHC Class I/Peptide Stability: Implications for Immunodominance, In Vitro Proliferation, and Diversity of Responding CTL. J. Immunol. 160: 4441-4448 [Abstract] [Full Text]
Vijh, S., Pilip, I. M., Pamer, E. G. (1998). Effect of Antigen-Processing Efficiency on In Vivo T Cell Response Magnitudes. J. Immunol. 160: 3971-3977 [Abstract] [Full Text]
Sandberg, J. K., Grufman, P., Wolpert, E. Z., Franksson, L., Chambers, B. J., Karre, K. (1998). Superdominance Among Immunodominant H-2Kb-Restricted Epitopes and Reversal by Dendritic Cell-Mediated Antigen Delivery. J. Immunol. 160: 3163-3169 [Abstract] [Full Text]
Uger, R. A., Barber, B. H. (1998). Creating CTL Targets with Epitope-Linked {beta}2-Microglobulin Constructs. J. Immunol. 160: 1598-1605 [Abstract] [Full Text]
Campos-Lima, P.-O. d., Levitsky, V., Imreh, M. P., Gavioli, R., Masucci, M. G. (1997). Epitope-dependent Selection of Highly Restricted or Diverse T Cell Receptor Repertoires in Response to Persistent Infection by Epstein-Barr Virus. JEM 186: 83-89 [Abstract] [Full Text]
Goulder, P.J.R., Sewell, A.K., Lalloo, D.G., Price, D.A., Whelan, J.A., Evans, J., Taylor, G.P., Luzzi, G., Giangrande, P., Phillips, R.E., McMichael, A.J. (1997). Patterns of Immunodominance in HIV-1-specific Cytotoxic T Lymphocyte Responses in Two Human Histocompatibility Leukocyte Antigens (HLA)-identical Siblings with HLA-A*0201 Are Influenced by Epitope Mutation. JEM 185: 1423-1433 [Abstract] [Full Text]
Sijts, A. J.A.M., Pamer, E. G. (1997). Enhanced Intracellular Dissociation of Major Histocompatibility Complex Class I-associated Peptides: A Mechanism for Optimizing the Spectrum of Cell Surface-Presented Cytotoxic T Lymphocyte Epitopes. JEM 185: 1403-1412 [Abstract] [Full Text]